Desitin Arzneimittel Gmbh
🇳🇴Norway
- Country
- 🇳🇴Norway
- Ownership
- Private
- Established
- 1919-01-01
- Employees
- 251
- Market Cap
- -
- Website
- http://www.desitin.de
SEDPARK1: Safety and Efficacy Study With the Non-ergot Dopamine-agonist Piribedil in Parkinson's Disease
Completed
- Conditions
- Parkinson's Disease
- First Posted Date
- 2008-07-30
- Last Posted Date
- 2010-03-31
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 250
- Registration Number
- NCT00725478
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Phase 3
Terminated
- Conditions
- Partial Epilepsy
- Interventions
- First Posted Date
- 2006-10-24
- Last Posted Date
- 2010-04-15
- Lead Sponsor
- Desitin Arzneimittel GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT00391534
© Copyright 2025. All Rights Reserved by MedPath